The disclosure relates to Compounds of Formula (I) and pharmaceutically acceptable derivatives thereof wherein Ar1, Ar2, L1 L2, X, R3, R22, and m are as defined herein, compositions comprising an effective amount of a Compound of Formula (I), and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a Compound of Formula (I).
本公开涉及式(I)的化合物及其药用可接受的衍
生物,其中Ar1、Ar2、L1、
L2、X、R3、
R22和m的定义如本文所述,包括有效量的式(I)化合物的组合物,以及用于治疗或预防疼痛、尿失禁、溃疡、炎症性肠病(IBD)和肠易激综合征(IBS)等疾病的方法,包括向需要的动物施用有效量的式(I)化合物。